Encompass Health Corporation (NYSE: EHC) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $13.5B. The Maz Rating grades it against the other companies in its sector.
Encompass Health Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $137.88, Encompass Health Corporation trades at 21.5x trailing earnings, 2.2x sales and 5.1x book value, with an EV/EBITDA of 10.5. Over the last twelve months it generated about $6.3B of revenue and $630M of net income. It runs a gross margin of 38.5%, an operating margin of 18.3% and a net margin of 10.2%. It shows return on equity of 25.2%, return on invested capital of 13.7% and a free cash flow yield of 3.4%. On the balance sheet: a debt-to-equity ratio of 1.05 and a current ratio of 1.09. Over the past 52 weeks the share price ranged from $92.77 to $143.90, with a beta of 0.60.
Encompass Health Corporation pays a dividend yielding 0.56%, with 12% of earnings paid out. Its Maz Dividend Score is 2.10 out of 5, ranked against the other dividend payers in its sector (Safety 4.10, Growth 1.97, Yield 2.03, Consistency 1.44).
27 Wall Street analyst ratings cover the stock: 1 Strong Buy, 21 Buy, 4 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Encompass Health Corporation (EHC) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 20.9% / 30% · (Cash+Inv) / Mkt Cap (36m) 0.61% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 20.9% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 0.61% / 33% · Receivables / Mkt Cap (36m) 5.73% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 20.9% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 0.61% / 33.33% · Receivables / Mkt Cap (24m) 5.73% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 32.6% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 1.80% / 33.33% · Receivables / Avg Assets (4Q) 9.16% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 34.4% / 33.33% · (Cash+ST Inv) / Total Assets 1.01% / 33.33% · (Cash+Recv) / Total Assets 10.4% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Encompass Health Corporation (EHC) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
Yes. Encompass Health Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Encompass Health Corporation reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.